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ABSTRACT 
Objective: The aim of this study was to perform the first ever investigation of the effect of activities in the nano capsules containing Geranium oil 
(NC1) against different species of pathogens such as Mycobacterium genus (both fast growing and slow growing), bacterial, and yeasts.  
Methods: The GO was analyzed by GC and GC/MS. Nano capsule suspensions (NC) were prepared by interfacial deposition of a preformed polymer 
method and the MICs were determined for the antimycobacterial, antimicrobial, and antifungal activities.  
Results: GO-loaded nano capsules (NC1) presented nano metric mean diameters (188 nm), polydispersity indices below 0.149, pH (5.5), and zeta 
potentials (about-10.8 mV). The MICs were determined for the antimycobacterial, antimicrobial, and antifungal activities. The NC1 was effective to 
Mycobacterium smegmatis (149.7 µg/ml), M. abscessos (35.9 µg/ml), M. massiliense (35.9 µg/ml), M. avium (71.8 µg/ml), Enterococcus faecalis, 
Streptococcus sp. (149.7 µg/ml) and Listeria monocytogenes (35.9 µg/ml). The NC1 was able to significantly reduce the number of cells of C. albicans 
(by approximately 5 log), 4 log the number of cells of C. dublinensis, C. glabrata, and C. krusei, and 2 log the number of cells of C. parapsilosis 
compared to the control group.  
Conclusion: Our study showed that the geranium oil-loaded nano capsules have antimycobacterial activities similar to free oil. The GO was effective 
in inhibiting the formation of germ tubes of Candida albicans, yet the nano capsule containing GO failed to inhibit the formation of this important 
virulence factor. 
Keywords: Nano capsule, Geranium oil, Antimycobacterial, Antimicrobial, Antifungal, Nanotechnology.  
 
INTRODUCTION 
Recently, the clinical use of essential oils has expanded worldwide to 
include therapy against various kinds of diseases, as leishmaniasis, 
malaria, Chagas, skin disorders, respiratory diseases among other. 
The antimicrobial and antifungal properties of essential oils have 
been documented and have acquired greater importance. Essential 
oils can be effective in the treatment or prevention of parasitic, 
bacterial and fungal diseases due to properties, such as low density 
and rapid diffusion across cell membranes [1-7]. 
The oil Pelargonium graveolens, also known as geranium oil or 
mauve is extracted from the tree Pelargonium odorantissimum 
originating from South Africa. The Pelargonium genus (Geraniaceae) 
is represented by many essential oil producing species: P. 
graveolens, P. odoranissimum, P. zonale, and P. roseum. Geranium oil 
(GO) is obtained from the leaves, flowers, and stalks using steam or 
hydrodistillation. The GO has historically been used in the treatment 
of dysentery, hemorrhoids, inflammation, heavy menstrual flows, 
and even cancer [8]. The French medicinal community currently 
treats diabetes, diarrhea, gallbladder problems, gastric ulcers, liver 
problems, sterility, and urinary stones with GO. The main 
constituents responsible for biological activity are citronellol, 
geraniol, linalool, isomenthone, nerol, and citronellyl formate [9]. 
However, because of their chemical complexity, susceptibility to 
degradation, and volatility and insolubility in water, it is necessary 
to employ procedures to improve the oil’s stability, contributing to 
the product’s effectiveness. 
Nanostructured systems appear as a potential system for asset 
management with lipophilic character. An important advantage of 
these systems is their small size (below 1 mm). In addition, further 
advantages are the possibility of increasing the effectiveness and 
stability of formulations or active substances, as well as their 
gradual release in adequate doses. Thus, one of the most promising 
areas for the use of nano capsules is the vectorization of essential 
oils with antimicrobials activities [10-12]. 
Little is known about the biological activities of GO. The search for 
new antifungal and antimicrobial agents is an important field. The 
prevalence of resistance among key microbial pathogens is 
increasing at an alarming rate worldwide [13]. The antibacterial 
activity of essential oils depends on their chemical composition, 
climate, season, geographical conditions, harvest period, and 
distillation technique. Bacteria have a genetic ability for transmitting 
and acquiring resistance to drugs. Recently, antimycobacterial 
activity of oil Melaleuca alternifolia and nanoparticles across the 
different strains of mycobacteria were evidenced [14]. 
The fungi, like Candida, are opportunistic etiological agents. This 
means that the infection and the expansion occur only in the event of 
a predisposition of the host organism [15-18]. Studies indicate that 
geraniol, the major constituent of GO, shows activity against gram-
negative bacteria and some Candida species [19]. Studies have 
revealed that nanostructures could be a delivery system to enhance 
the stability and water solubility of essential oils [20,21]. The 
advantages compared with conventional drug-delivery systems 
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include improved efficacy, reduced toxicity, protection of active 
compounds, and enhanced biocompatibility [22].  
Szweda et al. [23] investigated the in vitro antifungal activity of selected 
essential oils, ethanolic extracts of propolis and silver on TiO2 
nanoparticles dropped against azole-resistant C. albicans, C. glabrata and 
C. krusei clinical isolates. Aiming to expand the utilization of GO and 
seeking to increase the use of this kind of medical form and take 
advantage of proven pharmacological actions of the essential oil, we 
evaluated the effect of GO-loaded nano capsules (NC1) against different 
species of pathogens, such as Mycobacterium genus (both fast growing 
as slow growing), bacterial, and yeasts for the first time. 
MATERIALS AND METHODS 
Acquisition of GO and reagents 
The geranium essential oil (Lot STD1012) was purchased from Seiva 
Brázilis Ativos Naturais Ltd, São Paulo, Brazil; Dimethyl sulfoxide 
(DMSO) was used to dilute GO. Amphotericin B, for an antifungal 
activity, and Amikacin, for antimicrobial activity, was used as 
controls in the experiments. 
Geranium oil analysis 
Oil composition and yield were analyzed using the gas 
chromatography (GC) carried out using an Agilent Technologies 
6890N GC-FID system, equipped with a DB-5 capillary column (30 m x 
0.25 mm x 2.5 mm film thickness) and connected to a flame ionization 
detector (FID). The injector and detector temperatures were set to 250 
°C. The carrier gas was helium with a flow rate of 1.3 ml/min. The 
thermal programmer was 100-280 °C at a rate of 10 °C/min. Two 
replicates of samples were processed in the same way. The injection 
volume of the GO was 1 μl [24]. GC-Mass Spectroscopy (GC-MS) 
analyses were performed on an Agilent Technologies Auto System XL 
GC-MS operating in the EI mode at 70 eV, equipped with a split/split 
less injector (250 °C). The transfer line temperature was 280 °C. 
Helium was used as a carrier gas (1.5 ml/min) and the capillary 
columns used were an HP 5MS (30 m x 0.25 mm x 2.5 µm film 
thickness) and an HP Innowax (30 m x 0.32 mm i.d., film thickness 
0.50 µm). The temperature programmed was the same as that used for 
the GC analyses. The injected volume was 1 μl of the essential oil.  
Identifying the constituents of GO was performed on the basis of 
retention index (RI), determined with reference to the homologous 
series of n-alkanes C7-C30, under identical experimental conditions, 
comparing with the mass spectra library search (NIST and Wiley), and 
with the mass spectra literature. The relative amounts of individual 
components were calculated based on the CG peak area (FID response). 
Preparation of the formulation 
Nano capsule suspensions (NC) were prepared (n = 3) by interfacial 
deposition of the preformed polymer method. Briefly, an organic 
phase composed of GO (0.9 g), sorbitan mono oleate (0.192 g), poly 
(e-caprolactone) (0.25 g), and acetone (67.0 ml) was added to an 
aqueous solution (133.0 ml) containing polysorbate 80 (0.192 g) and 
kept under moderate magnetic stirring for 10 minutes. The Nano 
capsule containing GO was labeled NC1 and a control Nano capsule 
(NC2) containing the same constituents of NC1 was produced but 
without GO. This Nano capsule was added to the (0.9 g) medium-
chain triglycerides (MCT). The organic solvent was then eliminated 
from both NC1 and NC2 in a rotary evaporator (Fisatom, São Paulo, 
Brazil) at 60 rpm and 30-35 °C temperature. The final volume of the 
formulations was fixed in 25 ml to obtain a concentration of 1% of 
oil (10 mg/ml). 
The particle sizes and polydispersity index (n=3) were measured by 
photon correlation spectroscopy (Malvern Zetasizer/Nanosizer®
Dilution of GO and nano particles 
) 
and zeta potential values were measured by electrophoretic 
mobility, after dilution of 20 μl samples in 20 ml of NaCl (1 mM). The 
pH value of the nano capsules was analyzed by Digimed direct 
readings potentiometer (São Paulo, Brazil) at room temperature. 
The density of the GO (0.92 g/ml) was determined, and the same 
dilution (1: 1) was performed in DMSO to reach a concentration of 
460 mg/ml(Solution I). Afterwards, dilution was made at 1:100 in a 
Middlebrook 7H9 base medium (antimycobacterial activity) or a 
Mueller-Hinton broth (antimicrobial activity) to yield a 
concentration of 4.600 µg/ml(Solution II). Then, 50 μl 
(antimycobacterial activity) or 200 μl (antimicrobial activity) of 
solution II were added to the first well of the microplates and, after 
homogenization, were moved to the same volume and so on, yielding 
final concentrations of: 2.300, 1.150, 575, 287.5, 149.7, 71.8, 35.9, 
17.9, 8.9, 4.4 μg/ml. NC1 (575 µg/ml) and NC2 were added to the 
first well and after homogenization were transferred to the second, 
and so on to give final concentrations of 287.5, 149.7, 71.8, 35.9, 
17.9, 8.9, 4.4 μg/ml, respectively. 
Antimycobacterial activity  
For the antimycobacterial activity of GO and NC1, four strains of 
genus Mycobacterium, three fast growing strains (Mycobacterium 
smegmatis ATCC 700084, M. abscessus ATCC 19977 and M. 
massiliense ATCC 48898) and one slow growing strains (M. avium 
LR541CDC) were used in the study. The mycobacterial strains were 
thawed, picked to Lowenstein-Jensen medium, and kept in an 
incubator until visible growth of the colonies. Subsequently, colonies 
were suspended in a Middlebrook 7H9 base medium supplemented 
with 10% OADC (oleic acid-albumin-dextrose-catalase) (Difco 
Laboratories, Detriod, Michigan) and 0.2% glycerol (MD7H9) then 
incubated for 3 to 7 days at 35±2 °C in a tube containing glass beads. 
This suspension was then homogenized in a vortex shaker and 
standardized to 0.5 on the Macfarland scale; the fast-growing 
mycobacteria suspension was further diluted in MD7H9 to a 
concentration of 1 x 105
Antimicrobial activity 
 UFC/ml. From this bacterial suspension, the 
assay was performed based on the protocol M7-A6 [25]. The assay 
was performed in microtiter plates of 96 wells in triplicate. Serial 
dilutions were performed GO, NC1, and NC2 as described above. A 
volume of 50 µl of each dilution was added to the well along with 50 
µl of each bacterial suspension. Were also carried out controls of the 
medium, the microorganism, GO, NC1, and NC2. The plates were 
sealed with parafilm before being sterilely capped to prevent 
contamination occurred and volatilized oil. Subsequently, the plates 
were incubated at 35±2 °C for 5 to 7 days in a humid chamber. The 
results were observed by the formation of bacteria dotted at the 
bottom of the wells. 
To evaluate the antimicrobial activity of GO and NC1, the following 
microorganisms were used: Enterococcus faecalis ATCC 29212, 
Listeria monocytogenes ATCC 7644, Klebsiella pneumoniae ATCC 
700603, Escherichia coli ATCC 35218, Escherichia coli ATCC 8739, 
Escherichia coli ATCC 25922 e Pseudomonas aeroginosa ATCC 340. 
Clinical isolates of Streptococcus sp, Staphylococcus aureus, Klebsiella 
pneumoniae KPC+(HCPA), Klebsiella pneumoniae KPC+(USP), 
Klebsiella pneumoniae, Salmonella enteritidis, Enterococcus sp, and 
Shigella flexneri. The determination of the minimum inhibitory 
concentration was performed based on the protocol M7-A7 [26]. The 
bacterial suspension was prepared in saline with a turbidity 
equivalent to tube 0.5 of the MacFarland scale (1 x 108 UFC/ml). 
Then, this suspension was diluted at 1:100 in a Mueller-Hinton 
broth, yielding as inoculum 1 x 106 UFC/ml. This suspension was 
inoculated with 10 μl (1 × 104
Antifungal activity 
 UFC) into each well already containing 
200 μl of different concentrations of the GO, NC1, and NC2 as 
described above. The microplates were incubated at 35±2 °C for 24 
hours, under aerobic conditions. The MIC (Minimal Inhibitory 
Concentrations) was defined as the lowest concentration of 
compounds that inhibits bacterial growth. This test was performed 
in triplicate on separate occasions. The 2,3,5-triphenyltetrazolium 
chloride was used as an indicator of bacterial growth. 
The fungal isolates used in the study included one strain of each 
species: the yeasts Candida albicans ATCC 14053, Candida tropicalis 
ATCC 66029, Candida glabrata ATCC 66032, Candida parapsilosis 
ATCC 22019, Candida krusei ATCC 6258, Candida geochares ATCC 
36852, Candida magnoliae ATCC 201379, Candida kefyr ATCC 66028, 
Candida guilliermondii ATCC 6260, Candida catenulata 10565, 
Candida membranaefaciens ATCC 201377, Candida lusitaneae ATCC 
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42720, Candida dublinienesis CBS 7987, and Malassezia furfur ATCC 
14521. All strains were inoculated on sabouraud dextrose agar and 
incubated at 35±2 °C for 24 hours before the tests. For M. furfur was 
added in sabouraud agar olive oil. Subsequently, five colonies were 
picked with a diameter of approximately 1 mm, which were 
suspended in 5 ml of sterile 0.85% saline. The resulting suspension 
was placed on a vortex mixer for 15 seconds, and the cell density 
was adjusted using a spectrophotometer, adding sufficient saline to 
obtain equivalent transmittance to that of a standard solution in 0.5 
McFarland scale at 530 wavelength. This procedure provided a 
standard yeast suspension containing 1 x 106 to 5 x 106 cells per ml. 
The suspension was produced making a 1:50 dilution followed by a 
1:20 dilution of the standard suspension in RPMI 1640 medium 
supplemented with L-glutamine (Sigma Chemical Co., St Louis, 
Missouri, USA), buffered with MOPS [acid 3-(N-morpholino-propane 
sulfonic acid)] (0.165 mol/l) (Sigma), pH 7.0, to give the inoculum 2-
fold concentrated used in the test (1 x 103to 5 x 103 UFC/ml). After 
100 μl of each concentration of GO, NC1, and NC2 (as described 
above) was diluted in RPMI, each was then transferred to a well and 
added to 100 μl of inoculum. The final concentration after 
inoculation test was 0.5 x 103 the 2.5 x 103
Inhibition of germ tube formation 
The suspension of C. albicans ATCC 14053 was prepared from 
colonies growing on Sabouraud agar for 24h dispersed in 0.85% 
saline. The suspension was standardized by spectrophotometer at 
530 nm resulting in a concentration of yeast cells of 1 x 10
 UFC/ml, as recommended 
by the document M27-A3 [27]. The microplates were incubated at 
37 °C for 48 hours in triplicate. The MIC was determined based on 
the lowest concentration of oil which completely inhibited the 
growth of yeasts. For a better understanding of the antifungal 
activity of the NC1 and NC2 front, the yeasts were held in the broth 
macro dilution method [28,29]. Briefly, the NC1 and NC2 were 
diluted to a final concentration of 50%, directly in RPMI 1640 
supplemented with L-glutamine (Sigma Chemical Co., St Louis, 
Missouri, USA), buffered with 0.165 mol/l MOPS [acid 3-(N-
morpholino-propane sulfonic acid)] (0.165 mol/l) (Sigma), pH 7.0. 
The method also follows the recommendations of the protocol M27-
A (CLSI), but with modifications: sterile 11 x 70 mm tubes were used 
and the final volume in each tube was 1 ml; the incubation time with 
the NC1 and NC2 was increased to 72 hours and the quantification of 
the number of colonies present was held at the beginning of 
treatment and at the end of it. For this, the fungi were inoculated on 
Sabouraud dextrose agar and incubated at 35±2 °C for 24 hours 
before the tests, the results were expressed as mean±SD of 
log/UFC/ml. All experiments were performed in triplicate, being 
used as growth control only for the suspension of each fungus. 
6–5 x 106 
UFC/ml.
The main components were citronellol (31.37%) and geraniol 
(10.34%). The chemical composition of the oil was similar to other 
previously studied species. Our study showed that the citronellol 
(31.37%), geraniol (10.34%), citronellyl formate (6.51%), and α-
guaiene (5.13%) were the major compounds in the oil, with minor 
quantities of geranyl tiglate (2.07%) and geranial (2.18%). Other 
constituents were found in smaller amounts (<2%). The results of 
chemical analysis of the GO are presented in table 1. 
 
Table 1: Composition of the geranium essential oil 
 A volume of 100 µl of citrated human plasma was added to 
each well of a sterile microplate. Then, 100 µl of GO at 
concentrations of 4.4, 8.9 e 17.9 µg/ml (MIC/2, MIC, MIC 2x), NC1 
with 287.5 µg/ml and NC2 were added to the wells. Subsequently, 
10 μl of the yeast suspension were added to each well. Control of 
germ tube formation was performed only with citrated human 
plasma and a yeast suspension. To verify the inhibition of germ tube 
formation, Amphotericin B (50 µg/ml) was used. The plate was 
incubated at 35 °C±2 for 2 hours. Inhibition of germ tube formation 
was estimated directly in a Neubauer chamber, and the results were 
expressed as percentage (%). All samples were tested in triplicate in 
two independent experiments. 
Statistical analysis 
Results were subjected to analysis of variance (ANOVA) and Tukey´s 
test to verify the accuracy of the data. Values p<0.05 were 
considered statistically different. In the comparisons between two 
variables, we used the nonparametric Wilcoxon Test; when 
comparisons involved three or more variables, we used the 
nonparametric Kruskal-Wallis. 
RESULTS AND DISCUSSION 
GC analysis 
Compounds RI RIa Geranium oils b 
Area (%) 
Linalool 1098 1098 3.46 
Isomenthone 1164 1159 4.21 
Citronellol 1228 1228 31.37 
Geraniol 1255 1253 10.34 
Citronellyl formate 1275 1275 6.15 
α-Guaiene 1439 1443 5.13 
6,9-Guaiadiene 1465 1465 5.09 
Relative proportions of the essential oil constituents were expressed 
as percentages. aRetention indices from literature [24]. bRetention 
indices experimental (based on homologous series of n-alkane C7-C30
Evaluation of the activity against Mycobacterium genus strains was 
analyzed. NC1 and GO showed to be active against M. abscessos, M. 
massiliense, M. Smegmatis and M. avium. The antimicrobial activity 
was also determined against different bacteria. The MIC 
demonstrated that NC1 and GO were able to inhibit bacterial growth 




The rose geranium oil consisted mainly of oxygenated monoterpenes 
and oxygenated sesquiterpenes. The data presented here are 
consistent with previous reports of Boukhatem et al. [30], which 
demonstrated that geranium oils are characterized by citronellol 
(29.13%) and geraniol (12.6%). Some differences can be observed in 
the chemical composition of geranium oil; this is due to a number of 
factors including differences in local climatic and geographical 
conditions, season at the collection, and fertilization [31, 32].  
The essential oils are composed of specific cells found in the leaves, 
flowers, seeds, stems and roots. The complex mixtures of volatile 
substances such as alcohols, esters, aldehydes, ketones, phenols, 
among others, are important properties and some of these 
hydrophobic components are responsible for antimicrobial and 
antifungal activities. The main constituents responsible for the 
biological activity of GO are citronellol, geraniol, linalool, isomenthone, 
nerol and citronellyl formate. Due to these components, the essential 
oil has a strong and antibacterial effect [33, 34].  
Physicochemical properties of nano capsules 
The NC containing essential GO (NC1) and NC containing MCT (NC2) 
appeared macroscopically homogeneous and opalescent. The 
physicochemical characteristics of the formulations are presented in 
table 2. 
GO-loaded nano capsules presented nanometric mean diameters 
(188 nm) as well as polydispersity indices below 0.149 indicating an 
adequate homogeneity of these systems. The formulation showed 
acid pH (5.5) and negative zeta potentials (about-10.8 mV). The 
negative zeta potential values presented by the samples are related 
to the presence of polysorbate 80, presenting a negative surface 
density of charge due to the presence of oxygen atoms in the 
molecules. GO, as well as other essential oils, has a pronounced odor 
that sometimes should be masked in formulations. This way, we 
analyzed the odor of our formulation, comparing the intensity of 
their odor with the pure essential oil. It is important to point out that 
the incorporation of GO in nano capsules allows for a considerable 
reduction in the odor of the oil. This result is in agreement with the 
ability of polymeric nano capsules to mask physicochemical 
properties of some substances [35]. 
Antimycobacterial and antimicrobial activity 
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Table 2: Physicochemical properties 
Formulation Particle size (nm) PDI* Zeta potential (mV) pH 
NC1 188±0.025 0.149±0.009 -10.8±0.08 5.5±0.1 
NC2 233.3±0.030 0.185±0.011 -10.7±0.09 5.8±0.09 
 * PDI: polydispersity index. 
 
Table 3: Antimycobacterial and antimicrobial activity (MIC µg/ml) of geranium essential oil, nanostructures using microdilution method 
Microorganism Geranium Oil NC1 NC2 
 MIC (µg/ml) MIC (µg/ml) MIC (µg/ml) 
M. abscessus ATCC19977 35.9 35.9 ND 
M. smegmatis ATCC 700084 35.9 149.7 ND 
M. massiliense ATCC 48898 35.9 35.9 ND 
M. avium LR541CDC 17.9 71.8 ND 
Enterococcus faecalis ATCC 29212 149.7 149.7 ND 
Streptococcus sp-IC 149.7 149.7 ND 
Sthaphylococcus aureus-IC 149.7 ND ND 
Listeria monocytogenes ATCC 7644 149.7 35.9 ND 
Pseudomonas aeroginosa ATCC 340 149.7 ND ND 
Salmonella enteritidis-IC 149.7 ND ND 
ND: not detected. 
 
After evaluating the antimycobacterial activity, it was observed that 
GO had activity against M. abscessos, M. massiliense, M. Smegmatis, 
and M. avium with low MIC values (17.9–35.9 µg/ml). The 
antimicrobial activity was also evaluated and observed for S. aureus, 
Streptococcus, Sthaphylococcus, Listeria monocytogenes, 
Pseudomonas aeruginosa, and Salmonella enteritidis (149.7 µg/ml). 
The obtained results for antimicrobial activity are also in accordance 
with the literature, showing that geranium oil has antimicrobial 
properties against all tested strains. The GO obtained from 
Pelargonium graveolens shows a very strong activity against the 
standard strain S. aureus (ATCC 433000) and also against the 
examined strains S. aureus obtained from the clinical materials. The 
values of MIC against clinical S. aureus strains ranged from 0.25 
µg/ml to 2.5 µg/ml [36]. Prabuseenivasan et al. [37] reported that 
the oil obtained from Pelargonium graveolens was used at 
concentrations higher than 12.8 mg/ml inhibited the growth of the S. 
aureus ATCC 25923. In another study, the aim was to determine the 
antimicrobial activity of GO against Gram-negative bacterial clinical 
strains. The microdilution broth method was used to check the 
inhibition of microbial growth at various concentrations of GO. The 
tested geranium oil was efficacious against Gram-negative 
pathogens [38].  
In our investigation, it has been found that NC1 is effective against M. 
abscessos, M. massiliense, M. Smegmatis, and M. avium with low MIC 
values (35.9–149.7 µg/ml) and E. faecalis ATCC29212, Streptococcus 
sp-IC and L. monocytogenes ATCC 7644. The NC1 showed no activity 
against other strains tested. Recently, Souza et al. [14] reported 
antimycobacterial activity of Melaleuca alternifolia nanoparticles 
with MICs ranged from 0.002 to 2.5%. To date, there are no reported 
studies using nano capsules containing GO with antimycobacterial 
activity for comparison. 
Antifungal activity 
The determination of the Minimal Inhibitory Concentration (MIC) 
was measured after dilution of GO following the M27A3 protocol; the 
results can be found in table 4.  
ND: not detected 
One can show that the GO showed a similar MIC (8.9 µg/ml) for the 
strains of C. albicans, C. kefyr, C. dubliniensis, C. glabrata, and C. 
lusitaneae. Interestingly, it also showed the same MIC to Malassezia 
furfur. C. krusei was observed to have a MIC of 17.9 mg l and C. 
guilliermondii an MIC of 149.7 mg l. This MIC value is observed for all 
the yeasts studied after contact with NC1. Because of this, the broth 
macrodilution method was used to evaluate the activity of NC1. The 
antifungal activity by the macrodilution method showed a reduction 
in the number of colony forming units (CFU/ml) between different 
species of Candida tested within 72 hours. The NC1 was able to 
significantly reduce the number of cells of C. albicans (CA) by 
approximately 5 log, 4 log the number of cells of C. dublinensis (CD), 
C. glabrata (CG) and C. krusei (CK) and 2 log the number of cells of C. 
parapsilosis (CP) compared to control (fig. 1). 
 
Table 4: Antifungal activity (MIC µg/ml) of geranium essential oil, nanostructures using the micro dilution method 
Microorganism Geranium Oil NC1 NC2 
MIC (µg/ml) MIC (µg/ml) MIC (µg/ml) 
C. tropicalis ATCC 66029 575 >149.7 ND 
C. geochares ATCC 36852 1150 >149.7 ND 
C. albicans ATCC 14053 8.9  >149.7 ND 
C. kefyr ATCC 66028 8.9 >149.7 ND 
C. parapsilosis ATCC 22019 1150 >149.7 ND 
C. guilliermondii ATCC 6260 149.7 >149.7 ND 
C. dublinienesis CBS 7987 8.9 >149.7 ND 
C. glabrata ATCC 66032 8.9 >149.7 ND 
C. krusei ATCC 6258 17.9 >149.7 ND 
C. lusitaneae ATCC 42720 8.9 >149.7 ND 
C. membranafaciens ATCC 201377 2300 >149.7 ND 
Malassezia furfur ATCC 14521 8.9 >149.7 ND 
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Fig. 1: Antifungal activity of the nano capsules containing Geranium 
oil after 72 hours incubation performed method by the 
macrodilution against different Candida species. Candida albicans 
(CA), Candida dublinensis (CD), Candida glabrata (CG), Candida 
krusei (CK) and Candida parapsilosis (CP). Values were statistically 
significant at p<0.05 when compared to a(growth control with NC1 
and NC2) and b
 
(NC1 with NC2). Data are expressed as means±SD of 
log/UFC/ml of at three independent experiments 
Fluconazole (FLC) susceptibility of isolates of Candida spp., (n = 42) and 
efficacy as well as the mechanism of anti-Candida activity of three 
constituents of geranium oil were evaluated. No fluconazole resistance 
was observed among the clinical isolates tested. Geraniol and geranyl 
acetate were equally effective; fungicidal at 0.064% v/v concentrations, 
i.e., MICs (561 μg/ml and 584 μg/ml, respectively) and killed 99.9% 
inoculum within 15 and 30 min of exposures respectively [16]. Oliveira 
et al. [39] investigated the activity of the essential oil of Cymbopogon 
winterianus against fifteen strains of C. albicans by MIC. The MIC was 
determined by the microdilution method. The phytochemical analysis of 
the oil showed the presence of citronellal (23.59%), geraniol (18.81%) 
and citronellol (11.74%). The GO showed antifungal activity, and the 
concentrations 625 µg/ml and 1.250 µg/ml inhibited the growth of all 
strains tested and it was fungicidal, respectively. These results 
corroborate with the ours, where the GO showed high antifungal activity 
against C. albicans ATCC 14053, C. kefyr ATCC 66028, C. dubliniensis CBS 
7987, C. glabrata ATCC 66032, C. lusitaneae ATCC 6258 and Malassezia 
furfur ATCC 14521. Recently, Szweda et al. [23] revealed that essential 
oils, propolis and silver nanoparticles represent a high potential for 
controlling and prevention candidiasis. 
Inhibition of germ tube formation 
The effect of GO, NC1, and NC2 for germ tube formation was 
evaluated using a suspension of yeast in human plasm. GO values 
relating to the determined MIC microdilution test, half the MIC, and 
two times the MIC were employed. As for the NC1 and NC2, the same 
values as for the macrodilution tests were used. As a positive 
control, Amphotericin B (50 µg/ml) was used. After the incubation 
period of 2 hours, the treated yeast was quantified microscopically 
in a Neubauer chamber. It was observed that the concentration of 
GO related to MIC and twice the MIC could significantly inhibit germ 
tube formation in C. albicans. In NC1, NC2, and the negative control, 
it was possible to observe the formation of characteristic structures 
of the germ tube indicating no inhibition of their formation (fig. 2).  
 
 
Fig. 2: Inhibition of germ tube formation (%). Values were 
statistically significant at p<0.05 when compared to a(AnfB with 
growth control, GO, NC1 and NC2) and b(growth control, GO, NC1 
and NC2). Data are expressed as means±SD of at three 
independent experiments 
C. albicans is a polymorphic fungus that can present various 
morphologies for better adaptation to the environment. The 
formation of hyphae, pseudohyphae, and chlamydospores are 
important in their persistence in the site of infection and resistance 
to antifungal drugs [40]. The germ tube is the passage from the yeast 
form to the filamentous form of the fungus, where this process helps 
the yeast to penetrate and adhere more easily in cells. In our study, it 
was possible to observe that the GO was able to inhibit germ tube 
formation significantly when the concentration used was MIC/2 and 
MIC; however, such inhibition became more significant when the 
MIC value was doubled.  
Budzyńska et al.[41] proved that GO showed an inhibitory effect on 
germ tube formation in 95–100% at a concentration of 0.097% (v/v) 
of the cells compared with the control using RPMI supplemented with 
fetal bovine serum. In another study, the oil of Lavandula luisieri 
showed an inhibition of 95% more than the tube formation
CONCLUSION 
 [42]. 
However, NC1 has not inhibited germ tube formation of C. albicans. 
This may be due to the short exposure of the NC1, since this test was 
realized within two hours. To solve this problem, an alternative would 
be the use of nano emulsions because they are systems in which the 
GO could be more easily released. Thus, the contact of GO against the 
fungus would be faster and would possibly exert its effect. Nano 
capsules are used to increase the solubilization and absorption of 
lipophilic drugs [43]. These systems function as carriers, releasing 
substances of low water solubility that could be associated with oil 
droplets nanometers in size and/or system interface [44].  
The analysis of the geranium oil presented the citronellol and 
geraniol as major components. To prevent degradation of these 
compounds and increase their stability, nano capsules containing the 
oil were successfully produced. The obtained particles showed 
spherical conditions and mean diameters smaller than 200 nm. The 
physicochemical characteristics showed homogenous formulation, 
with polydispersity index and zeta potential suitability. Our study 
showed for the first time that the geranium oil-loaded nano capsules 
have antimycobacterial and antimicrobial activities similar to free 
oil. However, NC1 was not effective in inhibiting the formation of 
germ tubes of Candida albicans. 
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